Employee-Paid

The Food and Drug Administration approved 55 new treatments in 2023, representing a nearly 50% increase from the year before, with Pfizer gaining the highest number of high-profile approvals covering a wide range of illnesses.

Health and retirement benefits are more important now than they've ever been as employers compete for top talent, with employees' mental health now taking a more prominent place in a company's benefits package.

Benefits advisors can tap into new sales by helping employers explore new and expanded benefits plans.

Health Savings Accounts are increasingly being positioned as part of a holistic retirement savings approach, with nearly half (46%) of organizations using HSA auto-enrollment, according to a PSCA survey.

Despite the Biden administration's numerous initiatives to crack down on the high cost of drugs, several big drugmakers will hike prices this month, with Pfizer announcing over a quarter of the increases.

The Centers for Medicare & Medicaid Services prohibited such fees for EFTs until it was lobbied by a payment processor, then changed its position, however, a new bill would effectively force CMS to prohibit the fees.